Wordt geladen...
Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy
The aim of cancer immunotherapy is to treat malignant disease by inducing or enhancing cancer specific immune responses. With the identification of tumor-associated antigens (TAAs) in the 1990s, cancer immunotherapy research largely focused on inducing immune responses against TAAs but achieved limi...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
YJBM
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3238327/ https://ncbi.nlm.nih.gov/pubmed/22180678 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|